B. Clinton Inks Deal for Cheaper HIV Drugs

Former President Bill Clinton has struck an agreement with two drug companies to provide cheaper, better HIV treatments to patients in poor nations.

The deal involves antiretroviral medications made by Pfizer Inc. and Mylan Inc.

Clinton says the arrangement will lower the cost of the drug regimens to less than $500 per year.

The medications involved are used to treat people who have developed resistance to standard antiretroviral drugs.

The initiative is the latest in a string of HIV/AIDS price deals negotiated by Clinton's foundation since 2002.